Increased cancer risk for individuals with a family history of prostate cancer, colorectal cancer, and melanoma and their associated screening recommendations and practices
- PMID: 17906935
- DOI: 10.1007/s10552-007-9064-y
Increased cancer risk for individuals with a family history of prostate cancer, colorectal cancer, and melanoma and their associated screening recommendations and practices
Abstract
Prostate cancer, colorectal cancer, and melanoma are three malignancies that appear to have strong genetic components that can confer additional risk to family members. Screening tools, albeit controversial, are widely available to potentially aide in early diagnosis. Family members are now more attuned to the risks and benefits of cancer screening, thus, it is imperative that physicians understand the screening tools and how to interpret the information they provide. We reviewed the current literature regarding the cancer risks for individuals with a family history of prostate cancer, colon cancer, and melanoma, the current screening recommendations for family members, and actual screening practices of individuals with a family history of these malignancies. This review should serve as a guide for physicians and cancer control planners when advising their patients and the public regarding screening decisions.
Similar articles
-
Family history of cancer and utilization of prostate, colorectal and skin cancer screening tests in U.S. men.Prev Med. 2007 May;44(5):459-64. doi: 10.1016/j.ypmed.2006.12.016. Epub 2007 Jan 9. Prev Med. 2007. PMID: 17320159
-
Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.J Natl Cancer Inst. 2008 Sep 17;100(18):1318-25. doi: 10.1093/jnci/djn290. Epub 2008 Sep 9. J Natl Cancer Inst. 2008. PMID: 18780865
-
Relation of family history of prostate cancer to perceived vulnerability and screening behavior.Psychooncology. 2004 Feb;13(2):80-5. doi: 10.1002/pon.760. Psychooncology. 2004. PMID: 14872526
-
Screening participation in individuals with a family history of colorectal cancer: a review.Eur J Cancer Care (Engl). 2008 May;17(3):221-32. doi: 10.1111/j.1365-2354.2007.00834.x. Eur J Cancer Care (Engl). 2008. PMID: 18419625 Review.
-
Colorectal cancer: screening and surveillance for high-risk individuals.Expert Rev Anticancer Ther. 2003 Dec;3(6):851-62. doi: 10.1586/14737140.3.6.851. Expert Rev Anticancer Ther. 2003. PMID: 14686707 Review.
Cited by
-
Family history of melanoma and Parkinson disease risk.Neurology. 2009 Oct 20;73(16):1286-91. doi: 10.1212/WNL.0b013e3181bd13a1. Neurology. 2009. PMID: 19841380 Free PMC article.
-
Disparities in cancer screening in individuals with a family history of breast or colorectal cancer.Cancer. 2012 Mar 15;118(6):1656-63. doi: 10.1002/cncr.26480. Epub 2011 Aug 25. Cancer. 2012. PMID: 22009719 Free PMC article.
-
Correlation between the germline methylation status in ERβ promoter and the risk in prostate cancer: a prospective study.Fam Cancer. 2016 Apr;15(2):309-15. doi: 10.1007/s10689-015-9850-8. Fam Cancer. 2016. PMID: 26547439
-
Prevalence of family history of breast, colorectal, prostate, and lung cancer in a population-based study.Public Health Genomics. 2010;13(7-8):495-503. doi: 10.1159/000294469. Epub 2010 Apr 9. Public Health Genomics. 2010. PMID: 20389042 Free PMC article.
-
Coherence and completeness of population-based family cancer reports.Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):799-810. doi: 10.1158/1055-9965.EPI-09-1138. Epub 2010 Feb 16. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20160272 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical